Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
Stock Information for Apollomics Inc.
Loading
Please wait while we load your information from QuoteMedia.